Blog

10 Jan 2023

Biogen CEO Viehbacher outlines a path, including immunology, rare diseases

10 Jan 2023

BBJ/Seven Letter poll: Employees are looking for the exit if you don’t sta...

10 Jan 2023

What’s next for Leqembi, the new Biogen-Eisai Alzheimer’s drug?

9 Jan 2023

Poll: Likely voters say leave tax-cap law alone

9 Jan 2023

BizSpotlight: The Forsyth Institute

9 Jan 2023

MGH study finds Covid booster can last a year in healthy people

9 Jan 2023

Editas lays off 60, stops work on cancer, retinal disease

9 Jan 2023

Voyager, Neurocrine sign new deal worth up to $4.2B

9 Jan 2023

AstraZeneca reaches deal to buy CinCor Pharma for up to $1.8B

9 Jan 2023

Ipsen to buy liver disease drugmaker for $952M

9 Jan 2023

Rockland Trust CEO to step down, with ex-People’s exec to replace him

9 Jan 2023

This doctor wants to replace opioids with lasers for pain management